(RTTNews) - The Health Canada has approved Roche's Accu-Chek Inform II hospital blood glucose system for intensive care use. The Accu-Chek Inform II system supports Point of Care coordinators, ...

LAVAL, QC, June 9, 2021 /CNW Telbec/ - The Accu-Chek ® Inform II system (ACI II) supports Point of Care coordinators, physicians, nurses, IT experts and infection control managers to optimize their ...

ZURICH (Reuters) – The Food and Drug Administration (FDA) has given clearance for Roche’s new blood glucose monitor for hospital testing, the Swiss drugmaker said. Roche, which earlier on Tuesday ...

Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report by Product (Accu-Chek Inform II, Freestyle Lite), by Region (North America, ...

The networking and data management capabilities of Roche Accu-Chek® Inform II blood glucose meters connected to cobas® IT 1000 have allowed the Point of Care Testing (POCT) and diabetes teams at the ...

Roche has announced it has received FDA clearance for a blood glucose monitor for hospital point-of-care testing, according to a news release. The ACCU-CHEK Inform II system is described as a wireless ...

Evaluation of venous plasma glucose measured by point-of-care testing (Accu-Chek Inform II) and a hospital laboratory hexokinase method (Cobas c701) in oral glucose tolerance testing during pregnancy ...